The microbiome and the hallmarks of cancer
Open accessThe DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
How does the microbiota influence cellular proliferation and host cellular energetics?Normal tissues tightly regulate growth-promoting and death-inducing signals to maintain homeostatic cell densities, tissue architecture, and function.Dysregulation of these signaling pathways can lead to sustained cellular proliferation.The intercellular adhesion molecule, Ecadherin, is a common target engaged by intestinal bacteria that promotes epithelial proliferation by activating the Wnt/ß-catenin pathway.For example, enterotoxigenic Bacteroides fragilis (ETBF), resident among the microbiota of some individuals, secretes B. fragilis toxin (BFT)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, the gut microbiome can either be tumor-suppressive or oncogenic [22,23].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [22]
In the citing paper
“Several commensal bacteria play a probiotic role thanks to their capability to confer health benefits, either protecting against gut dysbiosis or enhancing host’s immune defense mechanisms [22,24].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
Cited by
Items 101–164 of 164
Anti-cancer Activity of Human Gastrointestinal BacteriaPreprint
Quazi, S. (2021) · Preprints.org · doi:10.20944/preprints202112.0433.v1 · Cited by 6
Microbiome dynamics in breast cancer: Mechanisms, therapeutic impacts and research gaps
Effiong, M. E., Ikeji, N. C., Bella-Omunagbe, M., Afolabi, I. S., & Chinedu, S. N. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104879 · Cited by 8
The Role of Obesity and Inflammation in Breast Cancer Recurrence
Chew, S. M., Liu, B., Shen, S., & Iyengar, N. M. (2024) · Current Breast Cancer Reports · doi:10.1007/s12609-024-00550-5 · Cited by 8
“The microbiome also plays a role in controlling the immune system and mediating inflammation [16].”
Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment
Rana, D., Salave, S., Perla, A., Nadkarni, A., Kolhe, S., Jindal, A. B., Mandoli, A., Dwivedi, P., & Benival, D. M. (2022) · Current Drug Targets · doi:10.2174/1389450123666220309101345 · Cited by 6
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review
Stella, G. M., Scialò, F., Bortolotto, C., Agustoni, F., Sanci, V., Saddi, J., Casali, L., Corsico, A. G., & Bianco, A. (2022) · Cancers · doi:10.3390/cancers14133131 · Cited by 7
RETRACTED ARTICLE: Anti-cancer activity of human gastrointestinal bacteria
Quazi, S. (2022) · Medical Oncology · doi:10.1007/s12032-022-01771-3 · Cited by 12
RetractedSkupa, S. A., Cooper, K. M., Smith, A. L., Drengler, E. M., Eiken, A. P., Schmitz, E. G., Waldron, G. M., Mathew, G., Primeaux, M., Dhawan, P., et al. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0022 · Cited by 7
Abolhassani, A., Esmaili, H., Rahati, S., & Jafarnejad, S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10741-w · Cited by 9
“These intestinal microbes impact both systemic and local physiological processes, including metabolic and immunological functions, which are significantly disrupted during carcinogenesis [53].”
Martín-Quesada, A. I., Hennessy, M., & Cardeña-Gutiérrez, A. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03595-1 · Cited by 4
Human Microbiome: Implication of Age and External Factors
Bashir, H., Bawa, A., & Kumar, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-7672-7_1 · Cited by 5
Ying, T., Lin, T.-C., Hong, Y., Zhou, Y., Sibeko, L. N., & Liu, Z. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.04.006 · Cited by 5
Soopramanien, M., Khan, N. A., & Siddiqui, R. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.14981 · Cited by 4
“These are classified as a group of bacteria that balances the gastrointestinal microbiota and induces health benefits (Fuller 1989).”
BackgroundUna visión integral del cáncer (II). Campos de estudio y biomarcadores emergentes
Noguera, R., Burgos‐Panadero, R., Gamero‐Sandemetrio, E., de la Cruz‐Merino, L., & Naranjo, T. Á. (2019) · Revista Española de Patología · doi:10.1016/j.patol.2019.04.005 · Cited by 4
Abril, A. G., Lanzi, P. G., & Notario, V. (2019) · Springer eBooks · doi:10.1007/978-3-030-21862-1_16 · Cited by 4
Maaty, S. E., Elashtokhy, M. M. A., Amin, M. K., Hassan, A. S., Zabermawi, N. M., Qattan, S. Y. A., Shafi, M. E., Algopishi, U. B., El-Shaboury, G. A., Farsi, R. M., et al. (2025) · Applied Food Research · doi:10.1016/j.afres.2025.100763 · Cited by 7
Insights into the gut microbiome-metabolite dynamics in breast cancer
Manzoor, H., & Kayani, M. U. R. (2025) · Gut Microbes Reports · doi:10.1080/29933935.2025.2483446 · Cited by 4
Microbiome implications in carcinogenesis initiation and promotion
Gheorghe, S.-A., Negru, Ş., Preda, M., Mihai, M. M., Manolescu, L. S. C., Popa, M. I., & Stănculeanu, D. L. (2020) · Oncolog-Hematolog ro · doi:10.26416/onhe.51.2.2020.3188 · Cited by 4
Al-Matouq, J. A., Hawra, A., Alibrahim, N., Alsaffar, N., Radwan, Z. H., & Ali, M. D. (2025) · Cancers · doi:10.3390/cancers17020226 · Cited by 3
Wu, Y., Zhou, M., Wan, Y., Wei, K., Ma, S., Cheng, L., Lin, T., He, L., He, Y., & Zhou, F. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1695187 · Cited by 3
“Once translocated into the nucleus, β -catenin acts as a transcription factor that promotes epithelial cell hyperproliferation (Fulbright et al., 2017).”
Ahn, J. A. O. K., Hazelton, A., Nguyen, J., & Arthur, J. C. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01725-z · Cited by 2
“Microbial metabolites and small molecules in fl uence multiple hallmarks of cancer — including genomic instability, chronic in fl ammation, and altered metabolism — integrating microbial activity into the broader framework of tumor biology 43 .”
Self-citationStreptococcus gallolyticus and its implication in colorectal cancer
Pardo, C. P., Gonzalez, R. C., Pinto, E. S., & Galiana, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819672-4.00003-9 · Cited by 2
Identifications of the potential in-silico biomarkers in lung cancer tissue microbiomes
Ma, Z. S., & Li, L. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109231 · Cited by 3
Jayaraman, V., Apthi, S., Datta, L., Baxi, D. B., Rajasekharan, S. K., Vasanthi, L., Palaniyandi, K., & Gnanasampanthapandian, D. (2024) · Springer eBooks · doi:10.1007/978-981-96-0297-1_3 · Cited by 3
Recent Advancements in Microbiome–Immune Homeostasis and their Involvement in Cancer Immunotherapy
Konatala, A., Parackel, F., & Pola, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_12 · Cited by 2
Chávez-Elizalde, B. P., Barrera-Vázquez, O. S., & Carrillo-Vega, M. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_9 · Cited by 2
Ma, Z. S., Li, L., & Mei, J. (2024) · medRxiv · doi:10.1101/2024.03.23.24304768 · Cited by 2
What is the relationship between penile cancer and the microbiome? A scoping review
García‐Perdomo, H. A., Granados-Duque, V., & Spiess, P. E. (2024) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2024.05.001 · Cited by 1
Gut microbiome and tumor immunotherapy
Vig, M., & Dubey, S. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.014 · Cited by 3
Pacheco-Barcía, V., Méndez, A. M., Hernández-Jiménez, E., Jiménez‐Fonseca, P., Martín, A. J. M., Custodio‐Cabello, S., Palka-Kotlowska, M., Gonzalez-Diaz, I., & Cabezón‐Gutiérrez, L. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i10.107877 · Cited by 1
The Human Gut Microbiota and Gastrointestinal Cancer: Current Status and Therapeutic Perspectives
Chowdhury, G., & Ramamurthy, D. (2022) · Springer eBooks · doi:10.1007/978-981-16-7672-7_4 · Cited by 1
Mechanism of Probiotic Action in Anticancer Immunity
Ragavan, M. L., & Das, N. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124781123030005 · Cited by 1
The Oral Microbiome in the Development of Oral Cancer
Сергеевна, К. Е., Schegoleva, A. A., Kononova, L. A., & Denisov, E. V. (2024) · Molecular Biology · doi:10.1134/s0026893324020092 · Cited by 1
Effects of Normal and Cancer Host Tissues on Microbiota Development, Persistence, and Dynamics
Amadei, S. S., & Notario, V. (2021) · Springer eBooks · doi:10.1007/978-3-030-77595-7_20 · Cited by 1
Giron, L. B., Peluso, M. J., Ding, J., Kenny, G., Zilberstein, N., Koshy, J., Hong, K. Y., Rasmussen, H. E., Miller, G., Bishehsari, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.12.488051 · Cited by 1
“Aging-associated diseases such as cancer, 241 diabetes, and Alzheimer’s are associated with specific gut microbial signatures (96-106).”
BackgroundExploring the causal role of the human gut microbiome in breast cancer risk
Edmunds, G. L., Robinson, T., Yarmolinsky, J., Lee, M. A., Hayes, B., Hughes, D. A., Gibbs, L., Braybrooke, J. P., Raes, J., Timpson, N. J., et al. (2026) · Wellcome Open Research · doi:10.1101/2025.02.12.25322118 · Cited by 1
Microbial community profiling of human gastrointestinal cancers
Thomas, A. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.95.2019.tde-07022019-134344
“Sources: Dzutsev et al. 2015 and Fulbright et al. 2017 …………………………………….”
Elie, C., Perret, M., Louis, K., Fritah, A., Leissner, P., Vachon, C., Rostaing, H., Reynier, F., Gervasi, G., & Saliou, A. (2020) · Research Square · doi:10.21203/rs.3.rs-52279/v1 · Cited by 2
Hanson, P. (1983) · PubMed Central
Salem, S., Azab, M. E., Safar, E. H., el-Shennawy, S. F., El-Shawarby, M., & Ia, E.-R. (1985) · PubMed
Khan, I. (2021) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0041-1735599 · Cited by 1
The human microbiome and the tumor microenvironment
Murphy, J. F. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00069 · Cited by 2
¿Cuál es la relación entre el cáncer de pene y el microbioma? Una revisión exploratoria
García‐Perdomo, H. A., Granados-Duque, V., & Spiess, P. E. (2024) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2024.01.012
Jing, L., Shuolin, S., Gongxian, M., Meng, X., Junhui, W., & Kai, W. (2024) · MEDS Clinical Medicine · doi:10.23977/medsc.2024.050117
“Studies have proven that microorganisms promote the occurrence and development of tumors by inducing tumor inflammation or translocating to tumor sites and sustaining cancer-induced inflammation [11-12].”
BackgroundGut Microbes: Role in Cancer and Cancer Drug Resistance
Mehraj, S., Fatima, K., Ali, S. Y., & Khan, S. U. (2024) · Springer eBooks · doi:10.1007/978-981-97-1666-1_10
Role of Immune Cells in Mediating the Effect of Gut Microbiota on Renal Cell CarcinomaPreprint
Wang, C., & Chen, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4634126/v1
Oral microbiome in the development of oral cancer
Сергеевна, К. Е., Schegoleva, A. A., Kononova, L. A., & Владимирович, Д. Е. (2024) · Molecular Biology · doi:10.31857/s0026898424020041
The Vaginal Microbiome: Setting the Stage for Cancer?
Doster, R. S. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae534 · Cited by 1
Chekhomov, S. Y., & Eliseev, Y. Y. (2024) · Saratov Journal of Medical Scientific Research · doi:10.15275/ssmj2003301
Vladimirova, E. V., & Shamova, O. V. (2025) · Medical academic journal · doi:10.17816/maj635890
One Flew Over the Cancer’s Nest
Paul, D. (2025) · Springer eBooks · doi:10.1007/978-3-032-08808-6_2
Biliary stents can modify the microbiota and promote the progression of pancreatic cancer
Fiordaliso, M., Pala, B., Marincola, G., Piscione, M., Savino, L., Mazzone, M., Marcantonio, M. C. D., & Mincione, G. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1633611 · Cited by 1
“Additionally, the authors investigate the interplay between chemotherapy and fungal dysbiosis, revealing that antifungal treatment can enhance the ef fi cacy of gemcitabine chemotherapy (71, 72).”
huang, K., Zhang, S., Liu, J., Yang, C., Zeng, G., & Li, B. (2026) · Physiological Genomics · doi:10.1152/physiolgenomics.00300.2025 · Cited by 1
Bingula, R. (2019) · theses.fr (ABES) · doi:10.70675/0634dca5z63c4z42bdza47azaf2d4eb69fd8 · Cited by 1
Zouiouich, S. (2021) · theses.fr (ABES) · doi:10.70675/dccac4fez891dz478eza9f4zd925044d3025 · Cited by 1
Fidelle, M. (2021) · theses.fr (ABES) · doi:10.70675/2168c5d5zc7cez4351zb678z1a8c9761484f
Stepanskyy, N., Meliani, J., Tökölyi, J., Nedelcu, A. M., Újvári, B., Frédéric Thomas, A., & Dujon, A. M. (2026) · Ecology and Evolution · doi:10.1002/ece3.73458
“…actively debated in the H. oligactis literature (Boutry et al. 2023; Rathje et al. 2020; Stepanskyy et al. 2025; Tissot, Meliani, Boutry, et al. 2024) and is increasingly supported by findings from other systems linking microbiota to cancer susceptibility (Fulbright et al. 2017; Garrett 2015).”
Ma, Z. S. (2026) · Medicine in Omics · doi:10.1016/j.meomic.2026.100063
The Microbial Conductor: Orchestrating Cancer Hallmarks through the Intratumoral Microbiome
Hamid, R. T., Ismael, D. H., Shihab, R. N., & Mohammed, N. (2026) · Iraqi Journal of Cancer and Medical Genetics · doi:10.29409/s5c44z69
Skupa, S. A., Hernandez, J. B., Smith, A. L., Drengler, E. M., Rai, J., Pan, J., Seth, A. K., Rai, S. N., Clayton, J. B., D'Angelo, C. R., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1842275 · Cited by 3
Jinhu, G., Li, Y., Yang, Y., & Wang, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1878878
“In particular, next-generation sequencing has signi fi cantly enhanced understanding of the microbiome ’ s diversity and its functional importance in solid tumors (13, 14, 16, 19 – 21).”
Levit, R., Carrasco, N., Cerasuolo, M. N., Yanez, P. A., de Macias, F. N., de LeBlanc, A. D. M., & LeBlanc, J. G. (2026) · Biochemistry · doi:10.5772/intechopen.1016385
Lewicka, M., Zawadzka, M., Zeman, K., Henrykowska, G. A., & Bąk‐Romaniszyn, L. (2026) · Nutrients · doi:10.3390/nu18203411
“In recent years, the pivotal role of the gut microbiota in human health and the pathogenesis of numerous diseases—including type 1 diabetes, obesity, deep vein thrombosis, cancer, and mental disorders—has become firmly established [11–15].”
Probiotics and oncology: Unlocking their potential for cancer treatment
Rana, R., Malothra, A., Kattel, K., Lalhlenmawia, H., Azizov, S., & Kumar, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45154-6.00002-7
Metadata
- Authors
- Fulbright, L. E., Ellermann, M., & Arthur, J. C.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Arthur, Janelle C.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-09-21
- Volume
- 13
- Issue
- 9
- Pages
- e1006480
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC5608396
- OpenAlex
- W2759449520
- Cited by
- 164
- References
- 160
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 21 · 2023: 19 · 2022: 21 · 2021: 21 · 2020: 24 · 2019: 20 · 2018: 9
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK103952)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- gut microbiota, cancer hallmarks, cell proliferation, E-cadherin, Wnt/β-catenin signaling, Bacteroides fragilis, enterotoxigenic Bacteroides fragilis, intestinal epithelial cells, tissue homeostasis
- MeSH terms
- Animals, Humans, Neoplasms, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
